These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365 [TBL] [Abstract][Full Text] [Related]
24. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Toltzis P; Jacobs MR Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653 [TBL] [Abstract][Full Text] [Related]
25. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants. Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172 [TBL] [Abstract][Full Text] [Related]
26. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Pletz MW; Maus U; Krug N; Welte T; Lode H Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). Oosterhuis-Kafeja F; Beutels P; Van Damme P Vaccine; 2007 Mar; 25(12):2194-212. PubMed ID: 17267077 [TBL] [Abstract][Full Text] [Related]
28. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121 [TBL] [Abstract][Full Text] [Related]
29. Pneumococcal conjugate vaccine for young children. Zimmerman RK Am Fam Physician; 2001 May; 63(10):1991-8. PubMed ID: 11388715 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449 [TBL] [Abstract][Full Text] [Related]
32. [Pneumococcal conjugate vaccine in children]. Lévy J; Swennen B Rev Med Brux; 2004 Sep; 25(4):A219-22. PubMed ID: 15516044 [TBL] [Abstract][Full Text] [Related]
33. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247 [TBL] [Abstract][Full Text] [Related]
34. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Albrich WC; Baughman W; Schmotzer B; Farley MM Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400 [TBL] [Abstract][Full Text] [Related]
35. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206 [TBL] [Abstract][Full Text] [Related]
37. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362 [TBL] [Abstract][Full Text] [Related]